Australian medicines safety updates in July 2021
Australian medicines safety updates in July 2021
About this item
Full title
Australian medicines safety updates in July 2021
Publisher
Auckland: Springer Nature B.V
Journal title
Reactions weekly, 2021-08 (1867), p.1-1
Language
English
Formats
Publication information
Publisher
Auckland: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Nifedipine: health professionals are advised that Product Information (PI) for nifedipine (Adalat, Adefin, Addos and APO-Nifedipine) has been updated on the risk of acute pulmonary oedema when the drug is used as a tocolytic agent for preterm labour.1 Although nifedipine use is contraindicated in pregnancy and during lactation, the TGA has received...
Alternative Titles
Full title
Australian medicines safety updates in July 2021
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2560407513
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2560407513
Other Identifiers
ISSN
0114-9954
E-ISSN
1179-2051
How to access this item
Log in as a Library member
